Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
 
Register | Sign in
Home Page>Products
  Product News
BioDiscovery Launches NxClinical™ Software
Wednesday, October 22, 2014
A unique solution for complete case review and reporting for genetics labs.

Magritek’s Benchtop NMR Used in Undergrad Teaching Program
Wednesday, October 22, 2014
Company’s Spinsolve Benchtop NMR spectrometer used at Long Beach City College under Dr Marlon Jones leadership.

Crisp and Fluid Imaging for Every Need - Olympus Full HD Cameras
Wednesday, October 22, 2014
Introducing the 5 megapixel DP27 and 3 megapixel DP22, Olympus presents its next generation of digital cameras for microscopy.

E-Learning: Bioreactors Made Easy!
Wednesday, October 22, 2014
The new Bioreactor Cultivation Video Guide from INFORS HT illustrates the operational steps using the Minifors and Labfors bench-top bioreactors as examples.

Bio-Rad Adds New PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, October 22, 2014
This release expands Bio-Rad’s current offering of predesigned and fully wet-lab validated assays.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

Bosch Debuts Flow Wrapper for Packaging Individual Vials in North America
Tuesday, October 21, 2014
Hermetic packaging for excellent product protection.

DNA Sequencing Analysis Kits Added to HIPAA Compliant Maverix Analytic Platform
Monday, October 20, 2014
Highly scalable analysis solutions for large volumes of whole genome, exome, and targeted resequencing data.

New Orbitrap-based Mass Spectrometer Launched
Monday, October 20, 2014
New Orbitrap-based mass spectrometer makes high-resolution accurate-mass analysis widely accessible.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 10615
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv